Stakeholder Research Priorities for Smoking Cessation Interventions Within Lung Cancer Screening Programs
For which topic were research priorities identified?
In which location was the research priority setting conducted?
North America - USA
Why was it conducted at all?
Smoking cessation counseling in conjunction with low dose computed tomography (LDCT) lung cancer screening is recommended in multiple clinical practice guidelines. The best approach for integrating effective smoking cessation interventions within this setting is unknown.
What was the objective?
to summarize evidence, identify research gaps, prioritize topics for future research, and propose standardized tools for use in conducting research on smoking cessation interventions within the LDCT lung cancer screening setting
What was the outcome?
a ranking list of 7 research questions
How long did the research prioritization take?
No information provided.
Which methods were used to identify research priorities?
How were the priorities for research identified exactly?
Step 1: multi-stakeholder committee formed. Step 2: meeting: summary of existing evidence and identified critical gaps presented, committee compiled several draft research questions in three areas through discussion, consensus through group discussion on 7 questions in each of the 3 areas. Step 3: survey: participants were asked to rank the 7 topics from 1 (most important) to 7 (least important) in each of the 3 areas
Which stakeholders took part?
Scientists, governmental and non-governmental funding agencies, professional societies, clinicians (physicians, nurses, and health educators specializing in pulmonary medicine, thoracic surgery, and/or tobacco dependence treatment), patients. 43 participants.
How were stakeholders recruited?
The project team identified stakeholders with expertise in tobacco dependence treatment, inviting all members of the ATS Tobacco Action Committee as of August 1, 2016. The project team also identified stakeholders with expertise in LDCT screening by recruiting from among experts who participated in the July 2016 National Academies of Science, Engineering, and Medicine Workshop on Implementation of Lung Cancer Screening. Finally, stakeholders with expertise in both tobacco dependence treatment and LDCT screening were identified by chairs and committee members and invited to participate in the online survey.
Were stakeholders actively involved or did they just participate?
Stakeholders were mere participants of the research prioritization process; they were not actively involved in the process.